Norman D Schwartz Bio Rad Laboratories, Inc. (BIO) insider trading activity

Norman D Schwartz is Chairman & CEO of BIO-RAD LABORATORIES, INC.. Currently has a direct ownership of 443,434 shares of BIO, which is worth approximately $120 Million. The most recent transaction as insider was on Sep 02, 2022, when has been sold 1,094 shares (Bio-Rad A Common Stock) at a price of $478.32 per share, resulting in proceeds of $523,282. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 443K

1.19% 3M change

1.19% 12M change

Total Value Held $120 Million

NORMAN D SCHWARTZ Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 02 2022	SELL Payment of exercise price or tax liability	$523,282 $478.32 p/Share	1,094 Reduced 0.26%	424,880 Bio-Rad A Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	-	1,805 Added 0.42%	425,974 Bio-Rad A Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$372,954 $486.25 p/Share	767 Reduced 0.18%	424,169 Bio-Rad A Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	1,266 Added 0.3%	424,936 Bio-Rad A Common Stock
Aug 26 2022	SELL Payment of exercise price or tax liability	$11,762,405 $495.28 p/Share	23,749 Reduced 6.68%	331,647 Bio-Rad B Common Stock
Aug 26 2022	BUY Exercise of conversion of derivative security	$4,212,310 $107.32 p/Share	39,250 Added 9.95%	355,396 Bio-Rad B Common Stock
Nov 09 2021	BUY Bona fide gift	-	20 Added 0.01%	316,146 Bio-Rad B Common Stock
Sep 07 2021	SELL Payment of exercise price or tax liability	$17,858,376 $806.32 p/Share	22,148 Reduced 6.55%	316,126 Bio-Rad B Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$2,001,200 $50.03 p/Share	40,000 Added 10.62%	336,786 Bio-Rad B Common Stock
Sep 05 2021	SELL Payment of exercise price or tax liability	$1,057,413 $819.7 p/Share	1,290 Reduced 0.3%	423,670 Bio-Rad A Common Stock
Sep 05 2021	BUY Exercise of conversion of derivative security	-	2,600 Added 0.61%	424,960 Bio-Rad A Common Stock
Sep 04 2021	SELL Payment of exercise price or tax liability	$1,057,413 $819.7 p/Share	1,290 Reduced 0.3%	422,360 Bio-Rad A Common Stock
Sep 04 2021	BUY Exercise of conversion of derivative security	-	2,600 Added 0.61%	423,650 Bio-Rad A Common Stock
Sep 03 2021	SELL Payment of exercise price or tax liability	$942,655 $819.7 p/Share	1,150 Reduced 0.27%	421,050 Bio-Rad A Common Stock
Sep 03 2021	BUY Exercise of conversion of derivative security	-	2,319 Added 0.55%	422,200 Bio-Rad A Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$739,064 $825.77 p/Share	895 Reduced 0.21%	419,881 Bio-Rad A Common Stock
Sep 02 2021	BUY Exercise of conversion of derivative security	-	1,805 Added 0.43%	420,776 Bio-Rad A Common Stock
Dec 04 2020	BUY Bona fide gift	-	27 Added 0.01%	298,274 Bio-Rad B Common Stock

NDS

Norman D Schwartz

Chairman & CEO

Hercules, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-RAD LABORATORIES, INC.

Track Activities on BIO

Account